MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


2020 3rd Quarter Results

RNS

RNS Number : 2577F
Hon Hai Precision Industry Co Ld
13 November 2020
 

HON HAI PRECISION INDUSTRY CO., LTD. AND SUBSIDIARIES CONSOLIDATED SHEETS

2020 3rd IFRSs Consolidated Financial Statements

 

Unit: NT$ thousand

Balance Sheet

Code

Accounting Title

2020/9/30

2019/12/31

2019/9/30


Assets





  Current assets




1100

  Cash and cash equivalents

1,018,518,545

857,864,362

788,552,993

1110

  Current financial assets at fair value through profit or loss

2,283,769

2,952,049

2,687,789

1136

  Current financial assets at amortised cost

56,982,365

52,954,877

80,674,247

1170

  Accounts receivable, net

674,576,103

987,278,438

973,106,359

1180

  Accounts receivable due from related parties, net

42,466,691

44,754,604

52,969,656

1200

  Other receivables

66,239,294

67,854,299

71,788,948

1210

  Other receivables due from related parties

7,020,715

24,366,543

29,532,400

130X

  Current inventories

707,992,299

515,772,177

690,816,511

1410

  Prepayments

20,411,757

19,895,574

19,866,243

11XX

  Total current assets

2,596,491,538

2,573,692,923

2,709,995,146


  Non-current assets




1510

  Non-current financial assets at fair value through profit or loss

89,046,993

82,660,725

80,915,973

1517

  Non-current financial assets at fair value through other comprehensive income

65,025,269

68,807,217

66,888,731

1535

  Non-current financial assets at amortised cost

19,190,490

12,528,569

14,172,490

1550

  Investments accounted for using equity method

164,428,944

168,631,642

170,025,603

1600

  Property, plant and equipment

278,138,570

287,523,253

272,040,082

1755

  Right-of-use assets

45,359,435

46,760,340

41,020,423

1760

  Investment property, net

10,111,512

4,419,912

4,591,843

1780

  Intangible assets

39,175,542

41,380,353

29,963,422

1840

  Deferred tax assets

23,088,696

18,701,465

16,671,351

1900

  Other non-current assets

14,041,943

15,835,299

8,796,992

15XX

  Total non-current assets

747,607,394

747,248,775

705,086,910

1XXX

  Total assets

3,344,098,932

3,320,941,698

3,415,082,056


Liabilities and equity





  Liabilities





  Current liabilities




2100

  Current borrowings

435,373,222

380,866,050

427,896,910

2110

  Short-term notes and bills payable

53,336,806

30,528,296

33,715,348

2120

  Current financial liabilities at fair value through profit or loss

1,405,078

1,881,685

1,831,892

2170

  Accounts payable

856,816,144

870,678,994

975,435,641

2180

  Accounts payable to related parties

28,856,701

35,509,127

43,124,578

2200

  Other payables

207,025,813

217,732,729

213,699,184

2230

  Current tax liabilities

18,512,527

18,531,289

22,700,301

2250

  Current provisions

2,632,722

2,725,293

2,546,871

2280

  Current lease liabilities

8,244,367

7,131,038

5,979,730

2300

  Other current liabilities

124,804,098

91,876,860

69,554,887

21XX

  Total current liabilities

1,737,007,478

1,657,461,361

1,796,485,342


  Non-current liabilities




2500

  Non-current financial liabilities at fair value through profit or loss

1,650

0

6,300

2530

  Bonds payable

158,033,607

175,505,344

181,220,286

2540

  Non-current portion of non-current borrowings

27,075,056

41,576,252

52,463,172

2550

  Non-current provisions

384,614

369,953

0

2570

  Deferred tax liabilities

20,651,693

18,261,509

20,205,461

2580

  Non-current lease liabilities

19,820,124

20,875,343

16,551,314

2600

  Other non-current liabilities

9,408,965

7,266,519

7,051,102

25XX

  Total non-current liabilities

235,375,709

263,854,920

277,497,635

2XXX

  Total liabilities

1,972,383,187

1,921,316,281

2,073,982,977


  Equity





  Equity attributable to owners of parent





  Share capital




3110

  Ordinary share

138,629,906

138,629,906

138,629,906

3100

  Total Share Capital

138,629,906

138,629,906

138,629,906


  Capital surplus




3210

  Capital surplus, additional paid-in capital

88,501,031

88,501,031

88,501,031

3230

  Capital surplus, difference between consideration and carrying amount of subsidiaries acquired or disposed

0

0

0

3235

  Capital Surplus, changes in ownership interests in subsidiaries

102,598,404

99,189,558

94,147,189

3250

  Capital surplus, donated assets received

0

0

0

3260

  Capital surplus, changes in equity of associates and joint ventures accounted for using equity method

10,092,638

10,593,529

10,944,906

3271

  Capital surplus, employee share options

0

0

0

3272

  Capital surplus, share options

1,099,253

1,099,253

1,099,253

3273

  Capital Surplus, restricted stock

0

0

0

3280

  Capital surplus, others

0

0

0

3200

  Total capital surplus

202,291,326

199,383,371

194,692,379


  Retained earnings




3310

  Legal reserve

161,043,748

149,512,874

149,512,874

3320

  Special reserve

102,451,720

60,309,927

60,309,927

3350

  Unappropriated retained earnings (accumulated deficit)

734,359,887

794,615,182

745,389,080

3300

  Total retained earnings

997,855,355

1,004,437,983

955,211,881


  Other equity interest




3410

  Exchange differences on translation of foreign financial statements

(139,388,384)

(113,889,466)

(86,080,108)

3420

  Unrealised gains (losses) from financial assets measured at fair value through other comprehensive income

11,511,403

11,437,746

4,246,979

3400

  Total other equity interest

(127,876,981)

(102,451,720)

(81,833,129)

3500

  Treasury shares

(15,194)

(15,194)

(15,194)

31XX

  Total equity attributable to owners of parent

1,210,884,412

1,239,984,346

1,206,685,843

36XX

  Non-controlling interests

160,831,333

159,641,071

134,413,236

3XXX

  Total equity

1,371,715,745

1,399,625,417

1,341,099,079

3X2X

  Total liabilities and equity

3,344,098,932

3,320,941,698

3,415,082,056

3997

  Number of share capital awaiting retirement

0

0

0

3998

  Equivalent issue shares of advance receipts for ordinary share

0

0

0

3999

  Number of shares in entity held by entity and by its subsidiaries

1,483,078

1,483,078

1,483,078

 

Unit: NT$ thousands   EPS Unit: NT$

Statement of Comprehensive Income

Code

Accounting Title

2020/7/1To9/30

2019/7/1To9/30

2020/1/1To9/30

2019/1/1To9/30


Operating revenue





4000

  Total operating revenue

1,291,541,100

1,387,792,029

3,349,011,129

3,601,878,654


Operating costs





5000

  Total operating costs

1,211,442,464

1,304,409,807

3,160,467,869

3,398,587,556

5900

Gross profit (loss) from operations

80,098,636

83,382,222

188,543,260

203,291,098

5950

Gross profit (loss) from operations

80,098,636

83,382,222

188,543,260

203,291,098


Operating expenses





6100

  Selling expenses

6,820,449

7,966,593

17,641,612

22,429,221

6200

  Administrative expenses

17,188,699

19,742,626

49,268,216

56,111,172

6300

  Research and development expenses

23,711,465

22,181,549

62,261,638

59,601,589

6000

  Total operating expenses

47,720,613

49,890,768

129,171,466

138,141,982

6900

Net operating income (loss)

32,378,023

33,491,454

59,371,794

65,149,116


Non-operating income and expenses






  Interest income





7100

  Total interest income

10,287,767

18,854,647

37,907,112

54,860,653


  Other income





7010

  Total other income

5,070,313

7,823,821

8,636,095

12,049,796


  Other gains and losses





7020

  Other gains and losses, net

776,131

(6,095,326)

5,913,511

2,119,902


  Finance costs





7050

  Finance costs, net

9,308,328

16,680,840

32,565,233

47,313,254


  Share of profit (loss) of associates and joint ventures accounted for using equity method





7060

  Share of profit (loss) of associates and joint ventures accounted for using equity method, net

3,721,084

4,663,655

4,428,030

14,227,828

7000

  Total non-operating income and expenses

10,546,967

8,565,957

24,319,515

35,944,925

7900

Profit (loss) from continuing operations before tax

42,924,990

42,057,411

83,691,309

101,094,041


Tax expense (income)





7950

  Total tax expense (income)

8,683,341

8,239,655

21,901,183

25,085,478

8000

Profit (loss) from continuing operations

34,241,649

33,817,756

61,790,126

76,008,563

8200

Profit (loss)

34,241,649

33,817,756

61,790,126

76,008,563


Other comprehensive income






  Components of other comprehensive income that will not be reclassified to profit or loss





8316

  Unrealised gains (losses) from investments in equity instruments measured at fair value through other comprehensive income

(3,303,339)

(3,382,569)

(2,610,510)

(717,439)

8320

  Share of other comprehensive income of associates and joint ventures accounted for using equity method, components of other comprehensive income that will not be reclassified to profit or loss

957,828

190,889

(2,600,380)

489,908

8310

  Components of other comprehensive income that will not be reclassified to profit or loss

(2,345,511)

(3,191,680)

(5,210,890)

(227,531)


  Components of other comprehensive income that will be reclassified to profit or loss





8361

  Exchange differences on translation

11,607,802

(38,361,969)

(26,905,249)

(23,823,291)

8370

  Share of other comprehensive income of associates and joint ventures accounted for using equity method, components of other comprehensive income that will be reclassified to profit or loss

1,614,384

(2,035,279)

(272,785)

553,746

8360

  Components of other comprehensive income that will be reclassified to profit or loss

13,222,186

(40,397,248)

(27,178,034)

(23,269,545)

8300

  Total other comprehensive income

10,876,675

(43,588,928)

(32,388,924)

(23,497,076)

8500

Total comprehensive income

45,118,324

(9,771,172)

29,401,202

52,511,487


Profit (loss), attributable to:





8610

  Profit (loss), attributable to owners of parent

30,854,592

30,664,317

55,818,855

67,542,884

8620

  Profit (loss), attributable to non-controlling interests

3,387,057

3,153,439

5,971,271

8,465,679


Comprehensive income attributable to:





8710

  Comprehensive income, attributable to owners of parent

40,701,498

(9,584,987)

26,223,229

46,117,730

8720

  Comprehensive income, attributable to non-controlling interests

4,416,826

(186,185)

3,177,973

6,393,757


Basic earnings per share





9710

  Basic earnings (loss) per share from continuing operations

2.23

2.21

4.03

4.87

9750

  Total basic earnings per share

2.23

2.21

4.03

4.87


Diluted earnings per share





9810

  Diluted earnings (loss) per share from continuing operations

2.21

2.19

4.00

4.83

9850

  Total diluted earnings per share

2.21

2.19

4.00

4.83

 



Unit: NT$ thousands

Statements of Cash Flows

 

Code

Accounting Title

2020/1/1To9/30

2019/1/1To9/30


Cash flows from (used in) operating activities, indirect method



A00010

  Profit (loss) from continuing operations before tax

83,691,309

101,094,041

A10000

  Profit (loss) before tax

83,691,309

101,094,041


  Adjustments




  Adjustments to reconcile profit (loss)



A20100

  Depreciation expense

44,888,883

47,838,884

A20200

  Amortization expense

3,162,402

1,208,492

A20300

  Expected credit loss (gain) / Provision (reversal of provision) for bad debt expense

1,982,168

967,176

A20400

  Net loss (gain) on financial assets or liabilities at fair value through profit or loss

(4,476,380)

(5,282,788)

A20900

  Interest expense

32,023,775

46,984,815

A21200

  Interest income

(37,907,112)

(54,860,653)

A21300

  Dividend income

(3,396,328)

(5,486,503)

A22300

  Share of loss (profit) of associates and joint ventures accounted for using equity method

(4,428,030)

(14,227,828)

A22500

  Loss (gain) on disposal of property, plan and equipment

339,891

467,545

A23100

  Loss (gain) on disposal of investments

(363,614)

78,074

A23500

  Impairment loss on financial assets

0

157,082

A23700

  Impairment loss on non-financial assets

0

138,896

A20010

  Total adjustments to reconcile profit (loss)

31,825,655

17,983,192


  Changes in operating assets and liabilities




  Changes in operating assets



A31115

  Decrease (increase) in financial assets at fair value through profit or loss, mandatorily measured at fair value

5,712,365

9,521,007

A31130

  Decrease (increase) in notes receivable

(87,046)

375,898

A31150

  Decrease (increase) in accounts receivable

311,128,001

34,947,002

A31160

  Decrease (increase) in accounts receivable due from related parties

3,735,107

(4,798,827)

A31180

  Decrease (increase) in other receivable

(9,408,360)

1,495,851

A31200

  Adjustments for decrease (increase) in inventories

(192,220,122)

(64,940,236)

A31230

  Decrease (increase) in prepayments

(516,183)

(269,983)

A31000

  Total changes in operating assets

118,343,762

(23,669,288)


  Changes in operating liabilities



A32125

  Increase (decrease) in contract liabilities

4,343,987

1,611,510

A32150

  Increase (decrease) in accounts payable

(13,862,850)

69,753,136

A32160

  Increase (decrease) in accounts payable to related parties

(6,652,426)

783,829

A32180

  Increase (decrease) in other payable

8,754,103

1,505,327

A32200

  Increase (decrease) in provisions

(77,910)

(3,105,276)

A32230

  Adjustments for increase (decrease) in other current liabilities

12,337,125

3,902,134

A32240

  Increase (decrease) in net defined benefit liability

146,531

(223,004)

A32000

  Total changes in operating liabilities

4,988,560

74,227,656

A30000

  Total changes in operating assets and liabilities

123,332,322

50,558,368

A20000

  Total adjustments

155,157,977

68,541,560

A33000

  Cash inflow (outflow) generated from operations

238,849,286

169,635,601

A33500

  Income taxes refund (paid)

(23,916,992)

(33,671,428)

AAAA

Net cash flows from (used in) operating activities

214,932,294

135,964,173


Cash flows from (used in) investing activities



B00010

  Acquisition of financial assets at fair value through other comprehensive income

(3,011,823)

(1,931,199)

B00020

  Proceeds from disposal of financial assets at fair value through other comprehensive income

3,206,871

864,354

B00040

  Acquisition of financial assets at amortised cost

(12,067,259)

(1,366,418)

B00060

  Proceeds from repayments of financial assets at amortised cost

1,279,800

1,369,020

B00100

  Acquisition of financial assets at fair value through profit or loss

(8,347,116)

(19,364,359)

B00200

  Proceeds from disposal of financial assets at fair value through profit or loss

2,493,641

12,590,164

B01800

  Acquisition of investments accounted for using equity method

(681,368)

(1,252,627)

B01900

  Proceeds from disposal of investments accounted for using equity method

496,722

0

B02200

  Net cash flow from acquisition of subsidiaries

(1,141,675)

(3,286,252)

B02700

  Acquisition of property, plant and equipment

(49,003,509)

(58,878,445)

B02800

  Proceeds from disposal of property, plant and equipment

2,534,904

2,122,108

B04400

  Decrease in other receivables due from related parties

16,025,396

27,157,760

B04500

  Acquisition of intangible assets

(671,586)

(49,624)

B05350

  Acquisition of use-of-right assets

(774,837)

(264,462)

B06800

  Decrease in other non-current assets

1,400,403

312,170

B07500

  Interest received

48,832,802

55,604,512

B07600

  Dividends received

8,511,162

10,291,713

B09900

  Other investing activities

348,479

0

BBBB

  Net cash flows from (used in) investing activities

9,431,007

23,918,415


Cash flows from (used in) financing activities



C00100

  Increase in short-term loans

54,507,172

0

C00200

  Decrease in short-term loans

0

(104,418,467)

C00500

  Increase in short-term notes and bills payable

22,811,117

14,498,375

C01200

  Proceeds from issuing bonds

21,050,000

31,060,000

C01300

  Repayments of bonds

(28,985,276)

(6,900,000)

C01600

  Proceeds from long-term debt

1,203,445

19,827,589

C01700

  Repayments of long-term debt

(5,208,949)

(948,194)

C04020

  Payments of lease liabilities

(6,330,697)

(3,650,739)

C04300

  Increase in other non-current liabilities

335,339

0

C04400

  Decrease in other non-current liabilities

0

(131,598)

C04500

  Cash dividends paid

(58,224,561)

(55,451,962)

C05600

  Interest paid

(46,257,075)

(50,971,434)

C05800

  Change in non-controlling interests

(1,987,711)

7,464,060

CCCC

  Net cash flows from (used in) financing activities

(47,087,196)

(149,622,370)

DDDD

Effect of exchange rate changes on cash and cash equivalents

(16,621,922)

(10,369,550)

EEEE

Net increase (decrease) in cash and cash equivalents

160,654,183

(109,332)

E00100

Cash and cash equivalents at beginning of period

857,864,362

788,662,325

E00200

Cash and cash equivalents at end of period

1,018,518,545

788,552,993

E00210

  Cash and cash equivalents reported in the statement of financial position

1,018,518,545

788,552,993

 


 

Unit: NT$ thousands

Statements of Change in Equity 

 


3110

3100

3200

3310

3320

3350

3300

3410

3420

3400

3500

31XX

36XX

3XXX

  Ordinary share

  Total share capital

  Capital surplus

  Legal reserve

  Special reserve

  Unappropriated retained earnings (accumulated deficit)

  Total retained earnings

  Exchange differences on translation of foreign financial statements

  Unrealised gains (losses) on financial assets measured at fair value through other comprehensive income

  Total other equity interest

  Treasury shares

  Total equity attributable to owners of parent

  Non-controlling interests

  Total equity

A1

  Equity at beginning of period

138,629,906

138,629,906

199,383,371

149,512,874

60,309,927

794,615,182

1,004,437,983

(113,889,466)

11,437,746

(102,451,720)

(15,194)

1,239,984,346

159,641,071

1,399,625,417

B1

  Legal reserve appropriated

0

0

0

11,530,874

0

(11,530,874)

0

0

0

0

0

0

0

0

B3

  Special reserve appropriated

0

0

0

0

42,141,793

(42,141,793)

0

0

0

0

0

0

0

0

B5

  Cash dividends of ordinary share

0

0

0

0

0

(58,224,561)

(58,224,561)

0

0

0

0

(58,224,561)

0

(58,224,561)

C7

  Changes in equity of associates and joint ventures accounted for using equity method

0

0

(500,891)

0

0

(6,557)

(6,557)

0

0

0

0

(507,448)

0

(507,448)

D1

  Profit (loss)

0

0

0

0

0

55,818,855

55,818,855

0

0

0

0

55,818,855

5,971,271

61,790,126

D3

  Other comprehensive income

0

0

0

0

0

0

0

(25,498,918)

(4,096,708)

(29,595,626)

0

(29,595,626)

(2,793,298)

(32,388,924)

D5

  Total comprehensive income

0

0

0

0

0

55,818,855

55,818,855

(25,498,918)

(4,096,708)

(29,595,626)

0

26,223,229

3,177,973

29,401,202

M7

  Changes in ownership interests in subsidiaries

0

0

3,408,846

0

0

0

0

0

0

0

0

3,408,846

0

3,408,846

O1

  Changes in non-controlling interests

0

0

0

0

0

0

0

0

0

0

0

0

(1,987,711)

(1,987,711)

Q1

  Disposal of investments in equity instruments designated at fair value through other comprehensive income

0

0

0

0

0

(4,170,365)

(4,170,365)

0

4,170,365

4,170,365

0

0

0

0

Y1

  Total increase (decrease) in equity

0

0

2,907,955

11,530,874

42,141,793

(60,255,295)

(6,582,628)

(25,498,918)

73,657

(25,425,261)

0

(29,099,934)

1,190,262

(27,909,672)

Z1

  Equity at end of period

138,629,906

138,629,906

202,291,326

161,043,748

102,451,720

734,359,887

997,855,355

(139,388,384)

11,511,403

(127,876,981)

(15,194)

1,210,884,412

160,831,333

1,371,715,745

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
QRTFFDSUDESSEFF